Drugs / Chimeric natriuretic peptide
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00699712 | Jun → Dec 2008 | heart failure | Nile Therapeutics | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Chimeric natriuretic peptide | “CD-NP (Chimeric natriuretic peptide)” NCT00699712 ↗ |
| Known as | CDNP | “Infusion of CDNP at two of four doses” NCT00699712 ↗ |
| Route | Intravenous | “intravenous (IV) administration of CD-NP” NCT00699712 ↗ |